You are here

clinical trials

Esperion tumbles as patient deaths weigh on cholesterol drug

Esperion tumbles as patient deaths weigh on cholesterol drug

Biopharma Dive

Esperion Therapeutics

clinical trials

Flag link:

Karyopharm to pursue FDA approval for multiple myeloma drug based on new study results

Karyopharm to pursue FDA approval for multiple myeloma drug based on new study results

Stat

Karyopharm Therapeutics

Multiple Myeloma

clinical trials

Flag link:

NanOlogy Completes Dose Escalation Portion of Phase 2 Trial of Unique NanoPac for Prostate Cancer

NanOlogy Completes Dose Escalation Portion of Phase 2 Trial of Unique NanoPac for Prostate Cancer

CP Wire

clinical trials

prostate cancer

Flag link:

GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out

GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out

Fierce Biotech

clinical trials

Flag link:

Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study

Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study

Endpoints

Alzheimer's disease

clinical trials

Flag link:

Eyeing blockbuster migraine market, Allergan unloads second set of positive PhIII results for ubrogepant

Eyeing blockbuster migraine market, Allergan unloads second set of positive PhIII results for ubrogepant

Endpoints

clinical trials

Flag link:

First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy

First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy

CP Wire

clinical trials

spinal muscular atrophy

Flag link:

AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study

AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study

CP Wire

rheumatoid arthritis

clinical trials

Flag link:

FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat

FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat

Xconomy

clinical trials

Flag link:

Merck’s Relebactam Met Primary Endpoints in Phase 3 Study

Merck’s Relebactam Met Primary Endpoints in Phase 3 Study

Market Realist

beta-lactamase inhibitors

clinical trials

Flag link:

Prothena’s lead drug NEOD001 just imploded in 2 late-stage studies — and there’s nothing left to salvage

Prothena’s lead drug NEOD001 just imploded in 2 late-stage studies — and there’s nothing left to salvage

Endpoints

clinical trials

Flag link:

ImmuPharma dives on late-stage lupus failure

ImmuPharma dives on late-stage lupus failure

Biopharma Dive

clinical trials

Flag link:

Solid Biosciences Provides Update on Clinical Hold of Ph I/II Trial for Duchenne Muscular Dystrophy (DMD)

Solid Biosciences Provides Update on Clinical Hold of Ph I/II Trial for Duchenne Muscular Dystrophy (DMD)

CP Wire

Solid Biosciences

Duchenne Muscular Dystrophy

clinical trials

Flag link:

Initial Ph II 2b Results of Elios' Personalized Cancer Vaccine for the Treatment of Melanoma Look Promising

Initial Ph II 2b Results of Elios' Personalized Cancer Vaccine for the Treatment of Melanoma Look Promising

CP Wire

Elios Therapeutics

clinical trials

Flag link:

Novocure touts top-line data from Ph2 mesothelioma trial

Novocure touts top-line data from Ph2 mesothelioma trial

Drug Delivery Business News

clinical trials

humanitarian device exemption

tumor treating fields

Flag link:

FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

Fierce Biotech

clinical trials

cystic fibrosis

Flag link:

CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys

CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys

MIT Technology Review

clinical trials

Flag link:

Despite Pain Drug’s Mid-Stage Miss, Adynxx Plans a Larger Phase 3 Test

Despite Pain Drug’s Mid-Stage Miss, Adynxx Plans a Larger Phase 3 Test

Xconomy

clinical trials

post-surgical pain

Flag link:

Bellicum Shares Up After Clinical Hold lifted on BPX-501

Bellicum Shares Up After Clinical Hold lifted on BPX-501

CP Wire

clinical trials

Flag link:

CymaBay Announces Positive Efficacy and Safety Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis

CymaBay Announces Positive Efficacy and Safety Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis

CP Wire

clinical trials

Flag link:

Pages